Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:70-8. doi: 10.1590/s0074-02762011000900009.
Malaria remains a major infectious disease that affects millions of people. Once infected with Plasmodium parasites, a host can develop a broad range of clinical presentations, which result from complex interactions between factors derived from the host, the parasite and the environment. Intense research has focused on the identification of reliable predictors for exposure, susceptibility to infection and the development of severe complications during malaria. Although most promising markers are based on the current understanding of malaria immunopathogenesis, some are also focused more broadly on mechanisms of tissue damage and inflammation. Taken together, these markers can help optimise therapeutic strategies and reduce disease burden. Here, we review the recent advances in the identification of malarial biomarkers, focusing on those related to parasite exposure and disease susceptibility. We also discuss priorities for research in biomarkers for severe malaria.
疟疾仍然是一种严重的传染病,影响着数百万人。一旦感染疟原虫寄生虫,宿主就会出现广泛的临床症状,这是由宿主、寄生虫和环境因素之间的复杂相互作用引起的。人们对识别暴露、感染易感性和疟疾严重并发症发展的可靠预测因子进行了深入研究。虽然大多数有前途的标志物都是基于对疟疾免疫发病机制的现有理解,但有些标志物也更广泛地关注组织损伤和炎症的机制。总的来说,这些标志物可以帮助优化治疗策略,减轻疾病负担。在这里,我们回顾了疟疾生物标志物鉴定的最新进展,重点关注与寄生虫暴露和疾病易感性相关的生物标志物。我们还讨论了严重疟疾生物标志物研究的重点。